Welcome back – as promised this is the bonus segment that was too good to leave in the Journal Club this month. Justin and I invited Dr Damian Roland back onto the podcast to discuss the new evidence which may guide our management of status epilepticus in children. Dr Damian Roland is an Emergency Paediatric […]
First10EM Journal Club: June 2019
June 4, 2019 By Leave a Comment
Welcome back to the Journal Club with Justin Morgenstern. This month I have a special bonus segment for you… but first, you have to go through all the usual cacophony of intellectual curiosity that Justin and I seem to indulge in periodically. Below are the papers that made the podcast this month for your reading […]
I: Vancomycin & the Nephrocidal Maniacs
May 14, 2019 By 2 Comments
Vancomycin was first isolated in 1953 by Edmund Kornfeld from a soil sample collected from the jungles of Borneo by a missionary. It is produced by the soil bacterium Amycolatopsis orientalis. It was first licensed for use in patients with penicillin resistant Staph infections in 1958. Yes, vancomycin has been around longer than the Beatles! […]
CREDENCE Trial PODCAST: Can-I-get-a-flozin?
May 10, 2019 By 1 Comment
The CREDENCE trial was published in the NEJM last month and it has made some waves in the world of diabetes management. The headlines state that this SGLT2 drug can reduce the progression of diabetic nephropathy. That is big news indeed. So, what do I think about this new data for a drug that had […]
Editorial: Ezetimibe and Etiquette
May 6, 2019 By 7 Comments
This is an editorial or rant, I guess it depends on your perspective. I have been contemplating for a few days if I should bother with this post. However, as a wise friend once counselled: “the standard that you walk past, is the standard that you accept.” So I have decided to write this in […]
Recent Comments